<--- Back to Details
First PageDocument Content
Pharmacology / Tylosin / Food and Drug Administration / Title 21 of the Code of Federal Regulations / Animal drugs / Federal Food /  Drug /  and Cosmetic Act / Paragraph / United States Code / Medicine / Food law / Health
Date: 2014-04-10 08:44:51
Pharmacology
Tylosin
Food and Drug Administration
Title 21 of the Code of Federal Regulations
Animal drugs
Federal Food
Drug
and Cosmetic Act
Paragraph
United States Code
Medicine
Food law
Health

[removed]Federal Register / Vol. 79, No[removed]Thursday, April 10, [removed]Rules and Regulations[removed], Version B, dated December 16, 2010, which are not incorporated by

Add to Reading List

Source URL: www.gpo.gov

Download Document from Source Website

File Size: 216,59 KB

Share Document on Facebook

Similar Documents

NEWS  The Cosmetics Industry OVERVIEW In the United States cosmetics are officially regulated by the Food & Drug Administration as a result of the Food, Drug and Cosmetic Act passed inThere is also a self-regulato

NEWS The Cosmetics Industry OVERVIEW In the United States cosmetics are officially regulated by the Food & Drug Administration as a result of the Food, Drug and Cosmetic Act passed inThere is also a self-regulato

DocID: 1uASt - View Document

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

DocID: 1tBOU - View Document

RETAIL COMPLIANCE CHECK INSPECTIONS AND FDA ACTIONS: AN OVERVIEW FOR TOBACCO RETAILERS Presented by Michelle Jackson

RETAIL COMPLIANCE CHECK INSPECTIONS AND FDA ACTIONS: AN OVERVIEW FOR TOBACCO RETAILERS Presented by Michelle Jackson

DocID: 1roDS - View Document

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

DocID: 1rmMY - View Document

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff

DocID: 1r7Xt - View Document